Cargando…
Human Neutrophils Respond to Complement Activation and Inhibition in Microfluidic Devices
Complement activation is key to anti-microbial defenses by directly acting on microbes and indirectly by triggering cellular immune responses. Complement activation may also contribute to the pathogenesis of numerous inflammatory and immunological diseases. Consequently, intense research focuses on...
Autores principales: | Muldur, Sinan, Vadysirisack, Douangsone D., Ragunathan, Sharan, Tang, Yalan, Ricardo, Alonso, Sayegh, Camil Elie, Irimia, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653703/ https://www.ncbi.nlm.nih.gov/pubmed/34899737 http://dx.doi.org/10.3389/fimmu.2021.777932 |
Ejemplares similares
-
Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation
por: Tang, Guo-Qing, et al.
Publicado: (2023) -
Corrigendum: Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation
por: Tang, Guo-Qing, et al.
Publicado: (2023) -
Prevention of Anti-HMGCR Immune-Mediated Necrotising Myopathy by C5 Complement Inhibition in a Humanised Mouse Model
por: Julien, Sarah, et al.
Publicado: (2022) -
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity
por: Fichtner, Miriam L., et al.
Publicado: (2022) -
Burn Injury Reduces Neutrophil Directional Migration Speed in Microfluidic Devices
por: Butler, Kathryn L., et al.
Publicado: (2010)